HomeDealsVida Pharma

Vida Pharma

Deal Type
Deal Type
Vital Sector
Completion Date
Completion Date
10th April 2024
Deal Value
Deal Value
Not disclosed

Company Background

Founded in 2004 in Crespina Lorenzana (Pisa), Vida Pharma is recognized on the market thanks to the high quality and innovation of hyaluronic acid-based biorevitalizers and fillers for the face and body and cosmetics, including peelings and mesotherapy. Vida guarantees the high performance of its products by taking care of the entire production process, from raw materials to the finished product. Vida distributes its vast range of products both under its own Ksurgery brand and in private labels, reaching the entire national territory and over 40 countries around the world through selected partners.

Deal Summary

Ethica Group, with the M&A and Debt Advisory teams, assisted White Bridge Investments in its entry into the capital of Vida Pharma, a company active in the development and production of injectable medical devices, cosmetics for professional and retail use.

Vida Pharma deal contacts

Key members of the Ethica Group deal team crucial in the Vida Pharma transaction

Beatrice Serina

Ethica Group